Home / Health / Weight Jab Users Face Flu Peril
Weight Jab Users Face Flu Peril
13 Dec
Summary
- Flu season poses dehydration risks for weight loss jab users.
- NHS facing worst-case flu scenario with high hospital bed occupancy.
- Skip weight loss jab doses if illness affects appetite, experts advise.
The current flu season is placing significant strain on the NHS, with hospital bed occupancy exceeding previous years and no peak in sight. Health officials are urging vaccination, but the 14-day effectiveness window means many are unprotected for Christmas. This poses a unique risk for the estimated 1.5 million people in the UK using weight loss jabs, such as Mounjaro and Wegovy.
Pharmacists highlight dehydration as a critical concern for these individuals. While some side effects of weight loss medications mimic flu symptoms, genuine flu infections require careful management. A key warning sign for jab users is a change in appetite; if illness makes eating difficult, experts recommend pausing medication doses to prevent dehydration and malnutrition.
Staying hydrated with sufficient fluids, electrolyte drinks, or rehydration solutions is crucial, especially when ill. Users should monitor for dehydration signs like dark urine and fatigue. While over-the-counter pain relief and rest are advised, individuals experiencing severe symptoms like breathing difficulties or confusion should seek immediate medical attention. Consulting a doctor for personalized guidance during illness is paramount.
